AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum
18 janv. 2017 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 18, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating...